Initial effectiveness of mRNA-1273 against SARS-CoV-2 infection and hospitalization in young children
Aglipay M, Maguire JL, Swayze S, Tuite A, Mamdani M, Keown-Stoneman C, Birken CS, Kwong JC. Open Forum Infect Dis. 2024; 12(1):ofae718.
Publications
COVID-19 vaccine effectiveness against severe omicron-related outcomes in children aged 5 to 11 years in Ontario: a Canadian immunization research network (CIRN) study
Piché-Renaud PP, Drover SSM, Austin PC, Morris SK, Buchan SA, Nasreen S, Schwartz KL, Tadrous M, Thampi N, Wilson SE, Wilson K, Guttmann A, Kwong JC. Vaccine. 2024; Nov 30 [Epub ahead of print].
Predicting risk of tuberculosis disease in people migrating to a low-TB incidence country: development and validation of a multivariable dynamic risk prediction model using health administrative data
Puyat JH, Brode SK, Shulha H, Romanowski K, Menzies D, Benedetti A, Duchen R, Huang A, Fang J, Macdonald L, Marras TK, Rea E, Kwong JC, Campitelli MA, Campbell JR, Schwartzman K, Cook VJ, Johnston JC. Clin Infect Dis. 2024; Nov 20 [Epub ahead of print].
Burden of illness associated with respiratory syncytial virus, influenza, and coronavirus disease 2019 in infants and young children in Ontario, Canada, 2018-2023: a population-based Canadian Immunization Research Network study
Jorgensen SCJ, Hernandez A, Buchan SA, Fitzpatrick T, Guttmann A, Morris SK, Kwong JC. Open Forum Infect Dis. 2024; 11(10):ofae601.
Quantifying the magnitude of the general contextual effect in a multilevel study of SARS-CoV-2 infection in Ontario, Canada: application of the median rate ratio in population health research
Watson T, Kwong JC, Kornas K, Mishra S, Rosella LC. Popul Health Metr. 2024; 22(1):27.
Association between maternal mRNA covid-19 vaccination in early pregnancy and major congenital anomalies in offspring: population based cohort study with sibling matched analysis
Jorgensen S, Drover S, Fell D, Austin P, D’Souza R, Guttmann A, Buchan S, Wilson S, Nasreen S, Brown K, Schwartz K, Tadrous M, Wilson K, Kwong J. BMJ Medicine. 2024; 3:e000743.
Effectiveness of modified vaccinia Ankara-Bavarian Nordic vaccine against mpox infection: emulation of a target trial
Navarro C, Lau C, Buchan SA, Burchell AN, Nasreen S, Friedman L, Okpokoro E, Austin PC, Tan DHS, Gubbay JB, Kwong JC, Mishra S. BMJ. 2024; 386:e078243. Epub 2024 Sep 11.
Coronavirus disease 2019 outcomes in a population-based cohort of people with HIV and a matched cohort of people without HIV during Omicron variant waves
Chambers C, Cooper CL, Kroch AE, Buchan SA, Kendall CE, Kwong JC, Moideddin R, Nguyen L, Arbess G, Benoit AC, Costiniuk CT, Habanyama M, Janjua NZ, Langlois MA, McCullagh J, Mbuagbaw L, Moqueet N, Nambiar D, Rueda S, Samji H, Tran V, Walmsley S, Anis A, Burchell AN; COVAXHIV Study Team. AIDS. 2024 Aug; 38(10):1597-1600.
Effect modification by statin use status on the association between fine particulate matter (PM2.5) and cardiovascular mortality
Bai L, Kwong JC, Kaufman JS, Benmarhnia T, Chen C, van Donkelaar A, Martin RV, Kim J, Lu H, Burnett RT, Chen H. Int J Epidemiol. 2024; 53(4):dyae084.
Pediatric respiratory syncytial virus hospitalizations, 2017-2023
Fitzpatrick T, Buchan SA, Mahant S, Fu L, Kwong JC, Stukel TA, Guttmann A. JAMA Netw Open. 2024; 7(6):e2416077. Epub 2024 Jun 11.